Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Prostate cancer patients try mediterranean diet before surgery in small feasibility study

NCT ID NCT04985565

First seen Sep 30, 2025 · Last updated Jun 19, 2026 · Updated 33 times

Summary

This small study tests whether men with intermediate-risk prostate cancer can follow a Mediterranean diet for a few weeks before their scheduled prostate removal surgery. The main goal is to see if this approach is practical and well-tolerated, not to cure the cancer. Researchers hope to learn how diet might influence health outcomes, which could guide future, larger studies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • M D Anderson Cancer Center

    Houston, Texas, 77030, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Mediterranean diet

What this could lead to

If successful, this could show that a short-term dietary change before surgery is practical and may improve overall health, pointing toward larger studies on diet and cancer outcomes.

What could go wrong

This is a very small, early feasibility study with only 12 participants, so results may not apply broadly. It is not designed to measure direct effects on cancer itself.

Conditions

The condition(s) this trial relates to.

prostate adenocarcinoma prostate cancer prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.